Skip to Main Content

Advertisement

American Association for Cancer Research Logo
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 10, Issue 10
15 May 2004
Clinical Cancer Research Cover Image for Volume 10, Issue 10
All Issues
ISSN 1078-0432
EISSN 1557-3265

Editorial

Imatinib for Small Cell Lung Cancer, Aiming for a Target in Vivo
Bruce E. Johnson
View articletitled, Imatinib for Small Cell Lung Cancer, Aiming for a Target <strong><em>in Vivo</em></strong>
Open the PDF for in another window

Reviews

Gene Expression Profiling in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Clinical Application
Russell D. Petty; Marianne C. Nicolson; Keith M. Kerr; Elaina Collie-Duguid; Graeme I. Murray
View articletitled, Gene Expression Profiling in Non-Small Cell Lung Cancer<span class="subtitle-colon">: </span><span class="subtitle">From Molecular Mechanisms to Clinical Application</span>
Open the PDF for in another window
Evidence-Based Use of Neoadjuvant Taxane in Operable and Inoperable Breast Cancer
Laura G. Estévez; William J. Gradishar
View articletitled, Evidence-Based Use of Neoadjuvant Taxane in Operable and Inoperable Breast Cancer
Open the PDF for in another window

The Biology Behind

Chemoresistance: Impact of Nuclear Factor (NF)-κB Inhibition by Small Interfering RNA : Commentary re J. Guo et al., Enhanced Chemosensitivity to Irinotecan by RNA Interference-Mediated Down-Regulation of the NF-κB p65 Subunit. Clin Cancer Res 2004;10:3333–3341
Ole Petter Veiby; Margaret A. Read
View articletitled, Chemoresistance: Impact of Nuclear Factor (NF)-κB Inhibition by Small Interfering RNA <span class="subtitle-colon">: </span><span class="subtitle">Commentary re J. Guo <strong><em>et al.</em></strong>, Enhanced Chemosensitivity to Irinotecan by RNA Interference-Mediated Down-Regulation of the NF-κB p65 Subunit. Clin Cancer Res 2004;10:3333–3341</span>
Open the PDF for in another window
Clinical Trials
A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar Trihydrochloride (LY335979), Administered Intravenously in Combination with Doxorubicin in Patients with Advanced Malignancy
Alan Sandler; Michael Gordon; Dinesh P. de Alwis; Isabelle Pouliquen; Lisa Green; Phil Marder; Ajai Chaudhary; Karen Fife; Linda Battiato; Christopher Sweeney; Christopher Jordan; Michael Burgess; Christopher A. Slapak
View articletitled, A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar Trihydrochloride (LY335979), Administered Intravenously in Combination with Doxorubicin in Patients with Advanced Malignancy
Open the PDF for in another window
Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating Factor
Gustav J. Ullenhag; Jan-Erik Frödin; Mahmood Jeddi-Tehrani; Karin Strigård; Emma Eriksson; Ali Samanci; Aniruddha Choudhury; Bo Nilsson; Eva D. Rossmann; Szilvia Mosolits; Håkan Mellstedt
View articletitled, Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating Factor
Open the PDF for in another window
Gene Expression in Gastrointestinal Stromal Tumors Is Distinguished by KIT Genotype and Anatomic Site
Cristina R. Antonescu; Agnes Viale; Lisa Sarran; Sylvia J. Tschernyavsky; Mithat Gonen; Neil H. Segal; Robert G. Maki; Nicholas D. Socci; Ronald P. DeMatteo; Peter Besmer
View articletitled, Gene Expression in Gastrointestinal Stromal Tumors Is Distinguished by <strong><em>KIT</em></strong> Genotype and Anatomic Site
Open the PDF for in another window
Molecular Oncology, Markers, Clinical Correlates
Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis
Karen H. Lu; Andrea P. Patterson; Lin Wang; Rebecca T. Marquez; Edward N. Atkinson; Keith A. Baggerly; Lance R. Ramoth; Daniel G. Rosen; Jinsong Liu; Ingegerd Hellstrom; David Smith; Lynn Hartmann; David Fishman; Andrew Berchuck; Rosemarie Schmandt; Regina Whitaker; David M. Gershenson; Gordon B. Mills; Robert C. Bast, Jr
View articletitled, Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis
Open the PDF for in another window
Disease-Stage Variance in Functional CD4+ T-Cell Responses Against Novel Pan-Human Leukocyte Antigen-D Region Presented Human Papillomavirus-16 E7 Epitopes
Dominic E. Warrino; Walter C. Olson; William T. Knapp; Meera I. Scarrow; Lori J. D’Ambrosio-Brennan; Richard S. Guido; Robert P. Edwards; W. Martin Kast; Walter J. Storkus
View articletitled, Disease-Stage Variance in Functional CD4<sup>+</sup> T-Cell Responses Against Novel Pan-Human Leukocyte Antigen-D Region Presented Human Papillomavirus-16 E7 Epitopes
Open the PDF for in another window
p73 Expression Is Associated with the Cellular Radiosensitivity in Cervical Cancer after Radiotherapy
Stephanie Si Liu; Rebecca Ching-Yu Leung; Kelvin Yuen-Kwong Chan; Pui-Man Chiu; Annie Nga-Yin Cheung; Kar-Fai Tam; Tong-Yow Ng; Ling-Chui Wong; Hextan Yuen-Sheung Ngan
View articletitled, p73 Expression Is Associated with the Cellular Radiosensitivity in Cervical Cancer after Radiotherapy
Open the PDF for in another window
Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis
Alan K. Meeker; Jessica L. Hicks; Christine A. Iacobuzio-Donahue; Elizabeth A. Montgomery; William H. Westra; Theresa Y. Chan; Brigitte M. Ronnett; Angelo M. De Marzo
View articletitled, Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis
Open the PDF for in another window
Experimental Therapeutics, Preclinical Pharmacology
Vascular Endothelial Growth Factor-Trap Suppresses Tumorigenicity of Multiple Pancreatic Cancer Cell Lines
Mitsuharu Fukasawa; Murray Korc
View articletitled, Vascular Endothelial Growth Factor-Trap Suppresses Tumorigenicity of Multiple Pancreatic Cancer Cell Lines
Open the PDF for in another window
Enhanced Chemosensitivity to Irinotecan by RNA Interference-Mediated Down-Regulation of the Nuclear Factor-κB p65 Subunit
Jun Guo; Udit N. Verma; Richard B. Gaynor; Eugene P. Frenkel; Carlos R. Becerra
View articletitled, Enhanced Chemosensitivity to Irinotecan by RNA Interference-Mediated Down-Regulation of the Nuclear Factor-κB p65 Subunit
Open the PDF for in another window
Hypoxia and Hypoxia-Inducible Factor-1 Target Genes in Central Nervous System Radiation Injury: A Role for Vascular Endothelial Growth Factor
Robert A. Nordal; Andras Nagy; Melania Pintilie; C. Shun Wong
View articletitled, Hypoxia and Hypoxia-Inducible Factor-1 Target Genes in Central Nervous System Radiation Injury<span class="subtitle-colon">: </span><span class="subtitle">A Role for Vascular Endothelial Growth Factor</span>
Open the PDF for in another window
Differential Up-Regulation of Cytosolic and Membrane-Bound Heat Shock Protein 70 in Tumor Cells by Anti-Inflammatory Drugs
Mathias Gehrmann; Marion Brunner; Karin Pfister; Albrecht Reichle; Elisabeth Kremmer; Gabriele Multhoff
View articletitled, Differential Up-Regulation of Cytosolic and Membrane-Bound Heat Shock Protein 70 in Tumor Cells by Anti-Inflammatory Drugs
Open the PDF for in another window

Regular Articles

Clinical Trials
A Randomized Phase II Trial of the Antiangiogenic Agent SU5416 in Hormone-Refractory Prostate Cancer
Walter M. Stadler; Dingcai Cao; Nicholas J. Vogelzang; Christopher W. Ryan; Kristin Hoving; Russell Wright; Theodore Karrison; Everett E. Vokes
View articletitled, A Randomized Phase II Trial of the Antiangiogenic Agent SU5416 in Hormone-Refractory Prostate Cancer
Open the PDF for in another window
Phase I Study of Bortezomib in Refractory or Relapsed Acute Leukemias
Jorge Cortes; Deborah Thomas; Charles Koller; Francis Giles; Elihu Estey; Stefan Faderl; Guillermo Garcia-Manero; David McConkey; Gira Patel; Roberto Guerciolini; John Wright; Hagop Kantarjian
View articletitled, Phase I Study of Bortezomib in Refractory or Relapsed Acute Leukemias
Open the PDF for in another window
Phase I and Pharmacokinetic Study of Irofulven Administered Weekly or Biweekly in Advanced Solid Tumor Patients
Jérôme Alexandre; Eric Raymond; Mahmoud Ould Kaci; Etienne C. Brain; François Lokiec; Carmen Kahatt; Sandrine Faivre; Alejandro Yovine; François Goldwasser; Sheri L. Smith; John R. MacDonald; Jean-Louis Misset; Esteban Cvitkovic
View articletitled, Phase I and Pharmacokinetic Study of Irofulven Administered Weekly or Biweekly in Advanced Solid Tumor Patients
Open the PDF for in another window
A Phase I and Pharmacological Study of the Platinum Polymer AP5280 Given as an Intravenous Infusion Once Every 3 Weeks in Patients with Solid Tumors
Jeany M. Rademaker-Lakhai; Catherine Terret; Stephen B. Howell; Christiane M. Baud; Richard F. de Boer; Dick Pluim; Jos H. Beijnen; Jan H. M. Schellens; Jean-Pierre Droz
View articletitled, A Phase I and Pharmacological Study of the Platinum Polymer AP5280 Given as an Intravenous Infusion Once Every 3 Weeks in Patients with Solid Tumors
Open the PDF for in another window

Research Articles

Molecular Oncology, Markers, Clinical Correlates
Analysis of Aberrant DNA Methylation and Human Papillomavirus DNA in Cervicovaginal Specimens to Detect Invasive Cervical Cancer and Its Precursors
Andreas Widschwendter; Conny Gattringer; Lennart Ivarsson; Heidi Fiegl; Alois Schneitter; Angela Ramoni; Hannes M. Müller; Annemarie Wiedemair; Susanne Jerabek; Elisabeth Müller-Holzner; Georg Goebel; Christian Marth; Martin Widschwendter
View articletitled, Analysis of Aberrant DNA Methylation and Human Papillomavirus DNA in Cervicovaginal Specimens to Detect Invasive Cervical Cancer and Its Precursors
Open the PDF for in another window
Cellular Immunity in Breast Cancer Patients Completing Taxane Treatment
William E. Carson, III; Charles L. Shapiro; Timothy R. Crespin; Lisa M. Thornton; Barbara L. Andersen
View articletitled, Cellular Immunity in Breast Cancer Patients Completing Taxane Treatment
Open the PDF for in another window
Identifying Superficial, Muscle-Invasive, and Metastasizing Transitional Cell Carcinoma of the Bladder: Use of cDNA Array Analysis of Gene Expression Profiles
Olga Modlich; Hans-Bernd Prisack; Gerald Pitschke; Uwe Ramp; Rolf Ackermann; Hans Bojar; Thomas A. Vögeli; Marc-Oliver Grimm
View articletitled, Identifying Superficial, Muscle-Invasive, and Metastasizing Transitional Cell Carcinoma of the Bladder<span class="subtitle-colon">: </span><span class="subtitle">Use of cDNA Array Analysis of Gene Expression Profiles</span>
Open the PDF for in another window
Expression of Extracellular Matrix Metalloproteases Inducer on Micrometastatic and Primary Mammary Carcinoma Cells
Natalie Reimers; Kristine Zafrakas; Volker Assmann; Cornelia Egen; Lutz Riethdorf; Sabine Riethdorf; Jürgen Berger; Sebastian Ebel; Fritz Jänicke; Guido Sauter; Klaus Pantel
View articletitled, Expression of Extracellular Matrix Metalloproteases Inducer on Micrometastatic and Primary Mammary Carcinoma Cells
Open the PDF for in another window
Reduced Lecithin: Retinol Acyltransferase Expression Correlates with Increased Pathologic Tumor Stage in Bladder Cancer
Stephen Boorjian; Satish K. Tickoo; Nigel P. Mongan; Huayin Yu; Dean Bok; Robert R. Rando; David M. Nanus; Douglas S. Scherr; Lorraine J. Gudas
View articletitled, Reduced Lecithin<span class="subtitle-colon">: </span><span class="subtitle">Retinol Acyltransferase Expression Correlates with Increased Pathologic Tumor Stage in Bladder Cancer</span>
Open the PDF for in another window
Genetic and Epigenetic Changes in p21 and p21B Do Not Correlate with Resistance to Doxorubicin or Mitomycin and 5-Fluorouracil in Locally Advanced Breast Cancer
Vidar Staalesen; Beryl Leirvaag; Johan Richard Lillehaug; Per Eystein Lønning
View articletitled, Genetic and Epigenetic Changes in <strong><em>p21</em></strong> and <strong><em>p21B</em></strong> Do Not Correlate with Resistance to Doxorubicin or Mitomycin and 5-Fluorouracil in Locally Advanced Breast Cancer
Open the PDF for in another window
Exon 15 BRAF Mutations Are Uncommon in Melanomas Arising in Nonsun-Exposed Sites
Yoram Cohen; Eli Rosenbaum; Shahnaz Begum; David Goldenberg; Clemens Esche; Ofer Lavie; David Sidransky; William H. Westra
View articletitled, Exon 15 <strong><em>BRAF</em></strong> Mutations Are Uncommon in Melanomas Arising in Nonsun-Exposed Sites
Open the PDF for in another window
Pak-1 Expression Increases with Progression of Colorectal Carcinomas to Metastasis
Julia H. Carter; Larry E. Douglass; James A. Deddens; Bruce M. Colligan; Tejal R. Bhatt; Jackson O. Pemberton; Susan Konicek; Joanne Hom; Mark Marshall; Jeremy R. Graff
View articletitled, Pak-1 Expression Increases with Progression of Colorectal Carcinomas to Metastasis
Open the PDF for in another window
Genomic Profiling of Viable and Proliferative Micrometastatic Cells from Early-Stage Breast Cancer Patients
Rainer Gangnus; Sabine Langer; Elisabeth Breit; Klaus Pantel; Michael R. Speicher
View articletitled, Genomic Profiling of Viable and Proliferative Micrometastatic Cells from Early-Stage Breast Cancer Patients
Open the PDF for in another window
Ability to Predict Metastasis Based On Pathology Findings and Alterations in Nuclear Structure Of Normal-Appearing and Cancer Peripheral Zone Epithelium in the Prostate
Robert W. Veltri; Masood A. Khan; M. Craig Miller; Jonathan I. Epstein; Leslie A. Mangold; Patrick C. Walsh; Alan W. Partin
View articletitled, Ability to Predict Metastasis Based On Pathology Findings and Alterations in Nuclear Structure Of Normal-Appearing and Cancer Peripheral Zone Epithelium in the Prostate
Open the PDF for in another window
Osteopontin as an Adjunct to CA125 in Detecting Recurrent Ovarian Cancer
John O. Schorge; Richard D. Drake; Hang Lee; Steven J. Skates; Ramababu Rajanbabu; David S. Miller; Jae-Hoon Kim; Daniel W. Cramer; Ross S. Berkowitz; Samuel C. Mok
View articletitled, Osteopontin as an Adjunct to CA125 in Detecting Recurrent Ovarian Cancer
Open the PDF for in another window
Rapid and Sensitive p53 Alteration Analysis in Biopsies from Lung Cancer Patients Using a Functional Assay and A Universal Oligonucleotide Array: A Prospective Study
Coralie Fouquet; Martine Antoine; Pascaline Tisserand; Reyna Favis; Marie Wislez; Fréderic Commo; Nathalie Rabbe; Marie France Carette; Bernard Milleron; Francis Barany; Jacques Cadranel; Gérard Zalcman; Thierry Soussi
View articletitled, Rapid and Sensitive p53 Alteration Analysis in Biopsies from Lung Cancer Patients Using a Functional Assay and A Universal Oligonucleotide Array<span class="subtitle-colon">: </span><span class="subtitle">A Prospective Study</span>
Open the PDF for in another window
Determination of Molecular Marker Expression Can Predict Clinical Outcome in Colon Carcinomas
Gennaro Galizia; Eva Lieto; Francesca Ferraraccio; Michele Orditura; Ferdinando De Vita; Paolo Castellano; Vincenzo Imperatore; Ciro Romano; Fortunato Ciardiello; Bruno Agostini; Carlo Pignatelli
View articletitled, Determination of Molecular Marker Expression Can Predict Clinical Outcome in Colon Carcinomas
Open the PDF for in another window
c-Kit Expression in Patients with Uterine Leiomyosarcomas: A Potential Alternative Therapeutic Treatment
Maria Rosaria Raspollini; Gianni Amunni; Alessandro Villanucci; Pamela Pinzani; Lisa Simi; Milena Paglierani; Gian Luigi Taddei
View articletitled, c-Kit Expression in Patients with Uterine Leiomyosarcomas<span class="subtitle-colon">: </span><span class="subtitle">A Potential Alternative Therapeutic Treatment</span>
Open the PDF for in another window
Expression Pattern of the Novel Gene EG-1 in Cancer
Liping Zhang; Raymond Scott Maul; JianYu Rao; Sophia Apple; David Seligson; Maryam Sartippour; Rosalio Rubio; Mai N. Brooks
View articletitled, Expression Pattern of the Novel Gene EG-1 in Cancer
Open the PDF for in another window
pRb2/p130, Vascular Endothelial Growth Factor, p27(KIP1), and Proliferating Cell Nuclear Antigen Expression in Hepatocellular Carcinoma: Their Clinical Significance
Pier Paolo Claudio; Giuseppe Russo; Christine A. C. Y. Kumar; Corrado Minimo; Antonio Farina; Steve Tutton; Gennaro Nuzzo; Felice Giuliante; Giulia Angeloni; Vellone Maria; Fabio Maria Vecchio; Cristiana Di Campli; Antonio Giordano
View articletitled, pRb2/p130, Vascular Endothelial Growth Factor, p27<sup>(KIP1)</sup>, and Proliferating Cell Nuclear Antigen Expression in Hepatocellular Carcinoma<span class="subtitle-colon">: </span><span class="subtitle">Their Clinical Significance</span>
Open the PDF for in another window
The 5A/6A Polymorphism of the Matrix Metalloproteinase 3 Gene Promoter and Breast Cancer
Peter Krippl; Uwe Langsenlehner; Wilfried Renner; Babak Yazdani-Biuki; Herwig Köppel; Andreas Leithner; Thomas C. Wascher; Bernhard Paulweber; Hellmut Samonigg
View articletitled, The 5A/6A Polymorphism of the Matrix Metalloproteinase 3 Gene Promoter and Breast Cancer
Open the PDF for in another window
Expression of the Forkhead Transcription Factor FOXP1 Is Associated with Estrogen Receptor α and Improved Survival in Primary Human Breast Carcinomas
Stephen B. Fox; Philip Brown; Cheng Han; Sally Ashe; Russel D. Leek; Adrian L. Harris; Alison H. Banham
View articletitled, Expression of the Forkhead Transcription Factor FOXP1 Is Associated with Estrogen Receptor α and Improved Survival in Primary Human Breast Carcinomas
Open the PDF for in another window
Experimental Therapeutics, Preclinical Pharmacology
Imatinib Mesylate Efficiently Achieves Therapeutic Intratumor Concentrations in Vivo but Has Limited Activity in a Xenograft Model of Small Cell Lung Cancer
Nicholas C. Wolff; Dwight E. Randle; Merrill J. Egorin; John D. Minna; Robert L. Ilaria, Jr.
View articletitled, Imatinib Mesylate Efficiently Achieves Therapeutic Intratumor Concentrations <strong><em>in Vivo</em></strong> but Has Limited Activity in a Xenograft Model of Small Cell Lung Cancer
Open the PDF for in another window
Suppressing Orthotopic Pancreatic Tumor Growth with a Fiber-Modified Adenovector Expressing the TRAIL Gene from the Human Telomerase Reverse Transcriptase Promoter
Dietmar Jacob; John Davis; Hongbo Zhu; Lidong Zhang; Fuminori Teraishi; Shuhong Wu; Frank C. Marini, III; Bingliang Fang
View articletitled, Suppressing Orthotopic Pancreatic Tumor Growth with a Fiber-Modified Adenovector Expressing the <strong><em>TRAIL</em></strong> Gene from the Human Telomerase Reverse Transcriptase Promoter
Open the PDF for in another window
A Comparison of the in Vitro and in Vivo Activities of IgG and F(ab′)2 Fragments of a Mixture of Three Monoclonal Anti-Her-2 Antibodies
Camelia I. Spiridon; Sarah Guinn; Ellen S. Vitetta
View articletitled, A Comparison of the <strong><em>in Vitro</em></strong> and <strong><em>in Vivo</em></strong> Activities of IgG and F(ab′)<sub>2</sub> Fragments of a Mixture of Three Monoclonal Anti-Her-2 Antibodies
Open the PDF for in another window
Improved Targeting of Pancreatic Cancer: Experimental Studies of a New Bispecific Antibody, Pretargeting Enhancement System for Immunoscintigraphy
Thomas M. Cardillo; Habibe Karacay; David M. Goldenberg; Dion Yeldell; Chien-Hsing Chang; David E. Modrak; Robert M. Sharkey; David V. Gold
View articletitled, Improved Targeting of Pancreatic Cancer<span class="subtitle-colon">: </span><span class="subtitle">Experimental Studies of a New Bispecific Antibody, Pretargeting Enhancement System for Immunoscintigraphy</span>
Open the PDF for in another window
The Roles of Thymidylate Synthase and p53 in Regulating Fas-Mediated Apoptosis in Response to Antimetabolites
Daniel Broderick Longley; Wendy Louise Allen; Ultan McDermott; Timothy Richard Wilson; Tariq Latif; John Boyer; Maria Lynch; Patrick Gerard Johnston
View articletitled, The Roles of Thymidylate Synthase and p53 in Regulating Fas-Mediated Apoptosis in Response to Antimetabolites
Open the PDF for in another window

Letter to the Editor

Confirmation of the Activity of the Interleukin-2 Fusion Toxin Denileukin Diftitox against Chemorefractory Chronic Lymphocytic Leukemia, including Cases with Chromosome 17p Deletions and without Detectable CD25 Expression
Susan J. Morgan; John F. Seymour; H. Miles Prince; David A. Westerman; Max M. Wolf
View articletitled, Confirmation of the Activity of the Interleukin-2 Fusion Toxin Denileukin Diftitox against Chemorefractory Chronic Lymphocytic Leukemia, including Cases with Chromosome 17p Deletions and without Detectable CD25 Expression
Open the PDF for in another window

Correction

Correction
View articletitled, Correction
Open the PDF for in another window

Advertisement

Latest News
How Unruly DNA Loops Are Shaping Cancer—and Treatments
Global Platform Delivering Kids’ Cancer Drugs to Countries in Need
Cancer Grand Challenges Throws Down Gauntlet
View more recent articles
Breaking
HHS to Eliminate 10,000 Jobs
pNET/epNET Drug Gets Thumbs Up
Ovarian Cancer Trial Brought to a Halt
View more recent articles
Research Watch
HIF Drives Expression of Immunogenic Endogenous Retroviruses in Cancer
Neurons Form GABAergic Synapses that Promote Diffuse Midline Glioma
Synonymous Mutations in m6A-modified Sites Can Destabilize Tumor Suppressors
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck.  None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept